<SEC-DOCUMENT>0001193125-20-083863.txt : 20200324
<SEC-HEADER>0001193125-20-083863.hdr.sgml : 20200324
<ACCEPTANCE-DATETIME>20200324165133
ACCESSION NUMBER:		0001193125-20-083863
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20200323
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200324
DATE AS OF CHANGE:		20200324

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MANNKIND CORP
		CENTRAL INDEX KEY:			0000899460
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				133607736
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50865
		FILM NUMBER:		20739017

	BUSINESS ADDRESS:	
		STREET 1:		30930 RUSSELL RANCH ROAD
		STREET 2:		SUITE 300
		CITY:			WESTLAKE VILLAGE
		STATE:			CA
		ZIP:			91362
		BUSINESS PHONE:		818-661-5000

	MAIL ADDRESS:	
		STREET 1:		30930 RUSSELL RANCH ROAD
		STREET 2:		SUITE 300
		CITY:			WESTLAKE VILLAGE
		STATE:			CA
		ZIP:			91362
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d905297d8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML><HEAD>
<TITLE>8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B><FONT
STYLE="white-space:nowrap">FORM&nbsp;8-K</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT
REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant to Section&nbsp;13 or 15(d) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): March&nbsp;23, 2020 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>MannKind Corporation </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">000-50865</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">13-3607736</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>incorporation or organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(IRS Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>30930 Russell Ranch Road, Suite 300</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Westlake Village, California</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>91362</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><B>(Address of principal executive offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area
<FONT STYLE="white-space:nowrap">code:&nbsp;(818)&nbsp;661-5000</FONT> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>N/A </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former name or former address, if changed since last report.) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the <FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions (see General Instruction A.2. of <FONT STYLE="white-space:nowrap">Form&nbsp;8-K):</FONT> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting material pursuant to <FONT STYLE="white-space:nowrap">Rule&nbsp;14a-12</FONT> under the Exchange Act
(17 <FONT STYLE="white-space:nowrap">CFR&nbsp;240.14a-12)</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to <FONT
STYLE="white-space:nowrap">Rule&nbsp;14d-2(b)</FONT> under the Exchange Act (17 <FONT STYLE="white-space:nowrap">CFR&nbsp;240.14d-2(b))</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to <FONT
STYLE="white-space:nowrap">Rule&nbsp;13e-4(c)</FONT> under the Exchange Act (17 <FONT STYLE="white-space:nowrap">CFR&nbsp;240.13e-4(c))</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&nbsp;12(b) of the Act: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title of each class</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Trading</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Symbol(s)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Name of each exchange</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>on which registered</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>MNKD</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>The Nasdaq Stock Market LLC</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of
1933 (&#167; 230.405 of this chapter) or <FONT STYLE="white-space:nowrap">Rule&nbsp;12b-2&nbsp;of</FONT> the Securities Exchange Act of 1934 <FONT STYLE="white-space:nowrap">(&#167;&nbsp;240.12b-2&nbsp;of</FONT> this chapter). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&nbsp;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth
company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange Act.&nbsp;&#9744;
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B>Item&nbsp;5.02</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers. </B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;23, 2020, Jennifer Grancio was appointed to the Board of Directors (the &#147;Board&#148;) of MannKind Corporation (the &#147;Company&#148;) and
the Audit Committee of the Board (the &#147;Audit Committee&#148;), effective immediately. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ms.&nbsp;Grancio is expected to receive compensation for
service as a director in accordance with the <FONT STYLE="white-space:nowrap">Company&#146;s&nbsp;non-employee&nbsp;director</FONT> compensation program, including an annual cash retainer and an annual equity grant. The Company will also enter into
an indemnification agreement with Ms.&nbsp;Grancio. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is no arrangement or understanding between Ms.&nbsp;Grancio and any other person pursuant to
which Ms.&nbsp;Grancio was appointed as director. The Company is not aware of any transaction between the Company and Ms.&nbsp;Grancio that would require disclosure under Item 404(a) of <FONT STYLE="white-space:nowrap">Regulation&nbsp;S-K.</FONT>
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;24, 2020, the Company issued a press release announcing the appointment of Ms.&nbsp;Grancio to the Board and the Audit Committee. A copy of
this press release is attached as Exhibit&nbsp;99.1 hereto. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Financial Statements and Exhibits. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="93%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exhibit</B><br><B>No.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Description</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d905297dex991.htm">Press Release, dated March&nbsp;24, 2020 </A></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">MANNKIND CORPORATION</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: March&nbsp;24, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Thomson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">David Thomson, Ph.D., J.D.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Corporate Vice President, General Counsel and Secretary</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d905297dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g905297mannkind1.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Jennifer Grancio Appointed to MannKind Board of Directors </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WESTLAKE VILLAGE, Calif., March&nbsp;24, 2020 &#151; MannKind Corporation (NASDAQ:MNKD) today announced that Jennifer Grancio has been appointed to its Board
of Directors, effective March&nbsp;23, 2020. Ms.&nbsp;Grancio will also serve as a member of the Audit Committee of the Board. Ms.&nbsp;Grancio brings to MannKind over twenty years of financial services experience and an expertise in creating
disruptive business models. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We are excited to welcome Ms.&nbsp;Grancio and her years of invaluable leadership to our board of directors,&#148; said
Kent Kresa, Chairman of the Board. &#147;Her financial services leadership experience will be an essential asset for MannKind as the company continues to grow. We are committed to surrounding ourselves with the best talent available, and the
appointment of Ms.&nbsp;Grancio reflects that effort.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ms.&nbsp;Grancio served as a founder and executive with BlackRock&#146;s iShares business
from 1999 to 2018. She spearheaded the distribution of iShares in the United States and Europe and acted as the Global Head of Marketing and Partnerships for BlackRock&#146;s indexing service. Through those efforts, Ms.&nbsp;Grancio established
herself as a global leader in exchange-traded and mutual funds. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since her time at BlackRock, she founded Grancio Capital, where she consults with company
leaders on the best ways to expand market reach and how to build effective teams to do so. Previously, she was a senior associate with PricewaterhouseCoopers, a management consulting firm. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ms.&nbsp;Grancio has served as a board member for Ethic, a sustainable investing firm, since November 2019. She serves on the board of Harvest
Savings&nbsp;&amp; Wealth as of Q1 2020 and is on the advisory boards of Say Technologies and m+ funds. Ms.&nbsp;Grancio is also active as a strategic advisor and speaker to organizations that are committed to developing diverse senior leaders and
to developing leadership in young women. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">She earned a bachelor&#146;s degree in economics and international relations from Stanford University, and an
MBA degree in strategy and finance from Columbia Business School. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With the addition of Ms.&nbsp;Grancio, there are nine members of the MannKind Board of
Directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About MannKind Corporation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MannKind
Corporation (NASDAQ: MNKD) focuses on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. MannKind is currently commercializing Afrezza<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (insulin human) Inhalation Powder, the Company&#146;s first <FONT STYLE="white-space:nowrap">FDA-approved</FONT> product and the only inhaled ultra rapid-acting mealtime insulin in the United
States, where it is available by prescription from pharmacies nationwide. MannKind is headquartered in Westlake Village, California, and has a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">state-of-the</FONT></FONT> art
manufacturing facility in Danbury, Connecticut. The Company also employs field sales and medical representatives across the U.S. For further information, visit www.mannkindcorp.com. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains
forward-looking statements that involve risks and uncertainties. Words such as &#147;believes,&#148; &#147;anticipates,&#148; &#147;plans,&#148; &#147;expects,&#148; &#147;intends,&#148; &#147;will,&#148; &#147;goal,&#148; &#147;potential&#148; and
similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon MannKind&#146;s current expectations. Actual results and the timing of events could differ
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g905297mannkind1.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties detailed in MannKind&#146;s filings with the SEC. For a discussion of these and
other factors, please refer to MannKind&#146;s annual report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December 31, 2019 as well as MannKind&#146;s other filings with the SEC. You are cautioned not to place undue
reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement, and MannKind undertakes no obligation to revise or
update any forward-looking statements to reflect events or circumstances after the date of this press release. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Company Contact: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">818-661-5000</FONT></FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ir@mannkindcorp.com </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g905297mannkind1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g905297mannkind1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  D -@# 2(  A$! Q$!_\0
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M!'K7.?$/_@X3^-WB'QQ/=>&M-\!>&M%5R]MIEUIDNI7"Q]O/F\^/<QZGRU0
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M:(_:S^+6C?M/?$BQLOBQ\3[.QL_&VM6]O:V_BJ^BAMXDU.X5(T190JHJ@*%
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M;EUYF]GVMT>MK6/R+P[R7B^AQ*ZV8JHJ?O>T<VW&6CM9O23YK6:V7EH>Y?L
M?\H8/VH_]^?_ -)HJ^4_V#_V<;;]K3]K?P7X!U"ZGL])UBYDGU.2!MLQM((S
M)*D;?PNX 0,.5W%AR!7U9_P3_.?^"+_[41_VY_\ TFBKR/\ X(E?\I+O ?\
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M8UZ@G)//:BBIE4E_92A?2^W3=BQ6)K?ZC4J7,^7GVN[?')[;;GSY_P %6_\
M@D_\)] \$Z_\4O#T.M^%=;DF$US8:5/"FF7<CR*&=H)(GV,=Q)\ID!)R0:^1
M_P#@D_\ L$^"_P!MGXL:A8^-+SQ$NFZ&C7'V33KJ.V2^",/W<K^69 ISSY;H
MWN***^IRNM4>3RFY.ZV=]MC]8X5S+%RX(K8AU9<\8M*7,[I*UK.]U\CZ$^-_
M_!'OX97GQR\32:?K'C+P_8G40;;3M-EL4M+!-D>(XE>U=@@[!F8^YHHHI83$
:571C>3V75G7E.98R6!H2E5DWR1^T^R\S_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
